Cargando…
Cox model and decision trees: an application to breast cancer data
OBJECTIVE. To evaluate, using semiparametric methodologies of survival analysis, the relationship between covariates and time to death of patients with breast cancer, as well as the determination discriminatory power in the conditional inference tree of patients who had cancer. METHODS. A retrospect...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Organización Panamericana de la Salud
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956854/ https://www.ncbi.nlm.nih.gov/pubmed/35350458 http://dx.doi.org/10.26633/RPSP.2022.17 |
_version_ | 1784676644204576768 |
---|---|
author | Pereira, Lucas Cardoso da Silva, Sóstenes Jerônimo Fidelis, Cleanderson Romualdo Brito, Alisson de Lima Xavier Júnior, Silvio Fernando Alves Andrade, Lorena Sofia dos Santos de Oliveira, Milena Edite Casé de Oliveira, Tiago Almeida |
author_facet | Pereira, Lucas Cardoso da Silva, Sóstenes Jerônimo Fidelis, Cleanderson Romualdo Brito, Alisson de Lima Xavier Júnior, Silvio Fernando Alves Andrade, Lorena Sofia dos Santos de Oliveira, Milena Edite Casé de Oliveira, Tiago Almeida |
author_sort | Pereira, Lucas Cardoso |
collection | PubMed |
description | OBJECTIVE. To evaluate, using semiparametric methodologies of survival analysis, the relationship between covariates and time to death of patients with breast cancer, as well as the determination discriminatory power in the conditional inference tree of patients who had cancer. METHODS. A retrospective cohort study was conducted using data collected from medical records of women who had breast cancer and underwent treatment between 2005 and 2015 at the Hospital da Fundação de Assistencial da Paraíba in Campina Grande, State of Paraiba, Brazil. Survival curves were estimated using the Kaplan–Meier method, Cox regression, and conditional decision tree. RESULTS. Women with triple-negative molecular subtypes had a shorter survival time compared to women with positive hormone receptors. The addition of hormone therapy reduced the risk of a patient dying by 5.5%, and the risk of a HER2-positive patient dying was 34.5% lower compared to those who were negative for this gene. Patients undergoing hormone therapy had a median survival time of 4 753 days. CONCLUSIONS. This paper shows a favorable scenario for the use of immunotherapy for patients with HER2 overexpression. Further studies could assess the effectiveness of immunotherapy in patients with other conditions, to favor the prognosis and better quality of life for the patient. |
format | Online Article Text |
id | pubmed-8956854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Organización Panamericana de la Salud |
record_format | MEDLINE/PubMed |
spelling | pubmed-89568542022-03-28 Cox model and decision trees: an application to breast cancer data Pereira, Lucas Cardoso da Silva, Sóstenes Jerônimo Fidelis, Cleanderson Romualdo Brito, Alisson de Lima Xavier Júnior, Silvio Fernando Alves Andrade, Lorena Sofia dos Santos de Oliveira, Milena Edite Casé de Oliveira, Tiago Almeida Rev Panam Salud Publica Original Research OBJECTIVE. To evaluate, using semiparametric methodologies of survival analysis, the relationship between covariates and time to death of patients with breast cancer, as well as the determination discriminatory power in the conditional inference tree of patients who had cancer. METHODS. A retrospective cohort study was conducted using data collected from medical records of women who had breast cancer and underwent treatment between 2005 and 2015 at the Hospital da Fundação de Assistencial da Paraíba in Campina Grande, State of Paraiba, Brazil. Survival curves were estimated using the Kaplan–Meier method, Cox regression, and conditional decision tree. RESULTS. Women with triple-negative molecular subtypes had a shorter survival time compared to women with positive hormone receptors. The addition of hormone therapy reduced the risk of a patient dying by 5.5%, and the risk of a HER2-positive patient dying was 34.5% lower compared to those who were negative for this gene. Patients undergoing hormone therapy had a median survival time of 4 753 days. CONCLUSIONS. This paper shows a favorable scenario for the use of immunotherapy for patients with HER2 overexpression. Further studies could assess the effectiveness of immunotherapy in patients with other conditions, to favor the prognosis and better quality of life for the patient. Organización Panamericana de la Salud 2022-03-23 /pmc/articles/PMC8956854/ /pubmed/35350458 http://dx.doi.org/10.26633/RPSP.2022.17 Text en https://creativecommons.org/licenses/by-nc-nd/3.0/us/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 IGO License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. No modifications or commercial use of this article are permitted. In any reproduction of this article there should not be any suggestion that PAHO or this article endorse any specific organization or products. The use of the PAHO logo is not permitted. This notice should be preserved along with the article’s original URL. Open access logo and text by PLoS, under the Creative Commons Attribution-Share Alike 3.0 Unported license. |
spellingShingle | Original Research Pereira, Lucas Cardoso da Silva, Sóstenes Jerônimo Fidelis, Cleanderson Romualdo Brito, Alisson de Lima Xavier Júnior, Silvio Fernando Alves Andrade, Lorena Sofia dos Santos de Oliveira, Milena Edite Casé de Oliveira, Tiago Almeida Cox model and decision trees: an application to breast cancer data |
title | Cox model and decision trees: an application to breast cancer data |
title_full | Cox model and decision trees: an application to breast cancer data |
title_fullStr | Cox model and decision trees: an application to breast cancer data |
title_full_unstemmed | Cox model and decision trees: an application to breast cancer data |
title_short | Cox model and decision trees: an application to breast cancer data |
title_sort | cox model and decision trees: an application to breast cancer data |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956854/ https://www.ncbi.nlm.nih.gov/pubmed/35350458 http://dx.doi.org/10.26633/RPSP.2022.17 |
work_keys_str_mv | AT pereiralucascardoso coxmodelanddecisiontreesanapplicationtobreastcancerdata AT dasilvasostenesjeronimo coxmodelanddecisiontreesanapplicationtobreastcancerdata AT fideliscleandersonromualdo coxmodelanddecisiontreesanapplicationtobreastcancerdata AT britoalissondelima coxmodelanddecisiontreesanapplicationtobreastcancerdata AT xavierjuniorsilviofernandoalves coxmodelanddecisiontreesanapplicationtobreastcancerdata AT andradelorenasofiadossantos coxmodelanddecisiontreesanapplicationtobreastcancerdata AT deoliveiramilenaeditecase coxmodelanddecisiontreesanapplicationtobreastcancerdata AT deoliveiratiagoalmeida coxmodelanddecisiontreesanapplicationtobreastcancerdata |